TY - JOUR
T1 - Mucus and mucus flake composition and abundance reflect inflammatory and infection status in cystic fibrosis
AU - Markovetz, Matthew R.
AU - Garbarine, Ian C.
AU - Morrison, Cameron B.
AU - Kissner, William J.
AU - Seim, Ian
AU - Forest, M. Gregory
AU - Papanikolas, Micah J.
AU - Freeman, Ronit
AU - Ceppe, Agathe
AU - Ghio, Andrew
AU - Alexis, Neil E.
AU - Stick, Stephen M.
AU - Ehre, Camille
AU - Boucher, Richard C.
AU - Esther, Charles R.
AU - Muhlebach, Marianne S.
AU - Hill, David B.
PY - 2022/11
Y1 - 2022/11
N2 - Background: Mucus hyperconcentration in cystic fibrosis (CF) lung disease is marked by increases in both mucin and DNA concentration. Additionally, it has been shown that half of the mucins present in bronchial alveolar lavage fluid (BALF) from preschool-aged CF patients are present in as non-swellable mucus flakes. This motivates us to examine the utility of mucus flakes, as well as mucin and DNA concentrations in BALF as markers of infection and inflammation in CF airway disease. Methods: In this study, we examined the mucin and DNA concentration, as well as mucus flake abundance, composition, and biophysical properties in BALF from three groups; healthy adult controls, and two CF cohorts, one preschool aged and the other school aged. BALFs were characterized via refractometry, PicoGreen, immunofluorescence microscopy, particle tracking microrheology, and fluorescence image tiling. Results: Mucin and DNA BALF concentrations increased progressively from healthy young adult controls to preschool-aged people and school-aged people with CF. Notably, mucin concentrations were increased in bronchoalveolar lavage fluid (BALF) from preschool-aged patients with CF prior to decreased pulmonary function. Infrequent small mucus flakes were identified in normal subjects. A progressive increase in the abundance of mucus flakes in preschool and school-aged CF patients was observed. Compositionally, MUC5B dominated flakes from normal subjects, whereas an increase in MUC5AC was observed in people with CF, reflected in a reduced flaked MUC5B/MUC5AC mucin ratio. Conclusion: These findings suggest mucus composition and flake properties are useful markers of inflammatory and infection-based changes in CF airways.
AB - Background: Mucus hyperconcentration in cystic fibrosis (CF) lung disease is marked by increases in both mucin and DNA concentration. Additionally, it has been shown that half of the mucins present in bronchial alveolar lavage fluid (BALF) from preschool-aged CF patients are present in as non-swellable mucus flakes. This motivates us to examine the utility of mucus flakes, as well as mucin and DNA concentrations in BALF as markers of infection and inflammation in CF airway disease. Methods: In this study, we examined the mucin and DNA concentration, as well as mucus flake abundance, composition, and biophysical properties in BALF from three groups; healthy adult controls, and two CF cohorts, one preschool aged and the other school aged. BALFs were characterized via refractometry, PicoGreen, immunofluorescence microscopy, particle tracking microrheology, and fluorescence image tiling. Results: Mucin and DNA BALF concentrations increased progressively from healthy young adult controls to preschool-aged people and school-aged people with CF. Notably, mucin concentrations were increased in bronchoalveolar lavage fluid (BALF) from preschool-aged patients with CF prior to decreased pulmonary function. Infrequent small mucus flakes were identified in normal subjects. A progressive increase in the abundance of mucus flakes in preschool and school-aged CF patients was observed. Compositionally, MUC5B dominated flakes from normal subjects, whereas an increase in MUC5AC was observed in people with CF, reflected in a reduced flaked MUC5B/MUC5AC mucin ratio. Conclusion: These findings suggest mucus composition and flake properties are useful markers of inflammatory and infection-based changes in CF airways.
KW - Airway mucus
KW - Gel-forming mucins
KW - Infection
KW - Microrheology
KW - Mucus flakes
UR - http://www.scopus.com/inward/record.url?scp=85128274150&partnerID=8YFLogxK
U2 - 10.1016/j.jcf.2022.04.008
DO - 10.1016/j.jcf.2022.04.008
M3 - Article
C2 - 35437233
AN - SCOPUS:85128274150
VL - 21
SP - 959
EP - 966
JO - Journal of Cystic Fibrosis
JF - Journal of Cystic Fibrosis
SN - 1569-1993
IS - 6
ER -